Bio Techne Corp Stock Alpha and Beta Analysis

TECH Stock  USD 75.36  0.02  0.03%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Bio Techne Corp. It also helps investors analyze the systematic and unsystematic risks associated with investing in Bio Techne over a specified time horizon. Remember, high Bio Techne's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Bio Techne's market risk premium analysis include:
Beta
1
Alpha
(0.03)
Risk
2.33
Sharpe Ratio
0.0453
Expected Return
0.11
Please note that although Bio Techne alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Bio Techne did 0.03  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Bio Techne Corp stock's relative risk over its benchmark. Bio Techne Corp has a beta of 1.00  . Bio Techne returns are very sensitive to returns on the market. As the market goes up or down, Bio Techne is expected to follow. The Bio Techne's current Book Value Per Share is estimated to increase to 13.77. The Bio Techne's current Tangible Book Value Per Share is estimated to increase to 3.92.

Enterprise Value

2.27 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Bio Techne Backtesting, Bio Techne Valuation, Bio Techne Correlation, Bio Techne Hype Analysis, Bio Techne Volatility, Bio Techne History and analyze Bio Techne Performance.

Bio Techne Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Bio Techne market risk premium is the additional return an investor will receive from holding Bio Techne long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Bio Techne. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Bio Techne's performance over market.
α-0.03   β1.00

Bio Techne expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Bio Techne's Buy-and-hold return. Our buy-and-hold chart shows how Bio Techne performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Bio Techne Market Price Analysis

Market price analysis indicators help investors to evaluate how Bio Techne stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bio Techne shares will generate the highest return on investment. By understating and applying Bio Techne stock market price indicators, traders can identify Bio Techne position entry and exit signals to maximize returns.

Bio Techne Return and Market Media

The median price of Bio Techne for the period between Tue, Sep 3, 2024 and Mon, Dec 2, 2024 is 73.91 with a coefficient of variation of 4.2. The daily time series for the period is distributed with a sample standard deviation of 3.09, arithmetic mean of 73.61, and mean deviation of 2.44. The Stock received a lot of media exposure during the period.
 Price Growth (%)  
       Timeline  
1
Reform UK celebrate huge poll victory - Labour and Tories should be very worried
09/20/2024
2
Are Bio-Techne Corporations Fundamentals Good Enough to Warrant Buying Given The Stocks Recent Weakness
10/11/2024
3
Bio-Techne Co. to Issue Quarterly Dividend of 0.08 on November 22nd
11/01/2024
4
There May Be Reason For Hope In Bio-Technes Disappointing Earnings
11/06/2024
5
What Our Leaders Need to Know About Tech Policy
11/07/2024
6
DOGE Versus the Bureaucracy
11/14/2024
7
An Optimistic Assessment of Tech Policy, and More, Under Trump
11/21/2024
 
Bio Techne dividend paid on 22nd of November 2024
11/22/2024
9
Gemini Bioproducts, LLC Acquires Selected Fetal Bovine Serum Product Rights and Inventory from Bio-Techne
11/25/2024
10
BIO-TECHNE TO PRESENT AT THE CITI 2024 GLOBAL HEALTHCARE CONFERENCE
11/27/2024

About Bio Techne Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Bio or other stocks. Alpha measures the amount that position in Bio Techne Corp has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2021 2022 2023 2024 (projected)
Dividend Yield0.0036910.0039190.0044640.004241
Price To Sales Ratio12.311.299.746.9

Bio Techne Upcoming Company Events

As portrayed in its financial statements, the presentation of Bio Techne's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Bio Techne's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Bio Techne's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Bio Techne. Please utilize our Beneish M Score to check the likelihood of Bio Techne's management manipulating its earnings.
1st of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of August 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

Build Portfolio with Bio Techne

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:
Bio Techne technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bio Techne technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bio Techne trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...